Search

Introduction: Despite a decline in Sudden Unexpected Death in Infancy in the UK since 2004, inequalities have widened with higher rates among families from deprived backgrounds and those known to child protection services. Almost all cases involve parents who had engaged in unsafe sleeping practices despite awareness of safer sleeping advice. Objective: To understand the perspectives surrounding safer sleep of families supported by statutory child protection agencies, and use behavior change theory to inform how approaches to providing safer sleep advice to these families may be modified. Participants and setting: We interviewed 14 mothers, 2 fathers and one grandmother, who had recent contact with child protection services in northeast England. Methods: In-depth, semi-structured interviews, with purposive sampling. The COM-B model (Capability, Opportunity, and Motivation) structured our analysis. Results: Parents described how anxiety, sleep deprivation, settling infants, illness, and a desire to bond with infants influence their decision making about sleep. Parents valued credible, trusted sources and understanding how safer sleep practices protect infants. Responses to questions about 'out of routine' situations suggested social pressures surrounding routines and 'good parenting' may preclude parents from acknowledging risks and planning for these situations. Conclusion: Open conversations tailored to the needs of families, focused upon understanding why and when parent(s) do or do not follow safer sleep guidance seem a promising way of promoting safer sleep practices. Safer sleep discussions with these families are likely to be best delivered as part of wider infant care by professionals who have an established and continuing trusting relationship with parents. While advice and information should be provided by any professional in contact with the family with the necessary expertise, sensitive conversations around sleeping practices, particularly co-sleeping, may be more easily facilitated by professionals where the statutory responsibility for safeguarding is less apparent. [ABSTRACT FROM AUTHOR]

Dressings continue to be a key part of successful wound care, however, choosing the right product for the right patient at the right time can be challenging for the clinician (Hedger, 2014). Modern foam dressings have been widely available since the mid-1970s with the aim to manage light-to-heavy exuding wounds (Hedger et al, 2014). Historically, bordered foam dressings have utilised acrylic-based adhesives; however, these have been associated with increased risk of skin sensitisation and medical adhesive-related skin injuries (MARSI; Meuleneire and Rucknagel, 2013; Hedger et al, 2014; Mestach et al, 2018; Downie and Collier, 2021). A clinical evaluation was undertaken to detail the characteristics and performance of Suprasorb® P sensitive silicone foam dressing (L&R Healthcare). The evaluation comprised a minimum of four dressing changes over at least 2 weeks. Fifty patients (51 wounds) were included in the evaluation. At the final evaluation, 57% (n=29) of the wounds were recorded as improved, 37% (n=19) were recorded as static and 6% (n=3) were recorded as having deteriorated. Of the 27% (n=14) evaluations where patients reported self caring, 71% scored Suprasorb P sensitive as above average for ease of use, suggesting the dressing may be suitable for patients who were self-caring and can apply their own dressing. Suprasorb P sensitive performed well in all the parameters evaluated and may be considered where effective exudate handling, improved patient comfort and ease of handling is required. [ABSTRACT FROM AUTHOR]

This article describes the evaluation in clinical practice of Kliniderm foam bordered and non-bordered, including the heel-shaped wound dressing on 25 patients over a twoweek period, with an average of four dressing changes and a minimum of two dressing changes. An evaluation form was completed at each dressing change, which aimed to elucidate particular aspects of the dressing's performance, considering: patient comfort on application, ease of application, conformability of the dressing, the dressing's ability to manage exudate, ability to stay in place, ease of removal and patient comfort on removal, the condition of the wound and the surrounding periwound skin. The ratings on evaluation forms were collated and an average rating was calculated for each category. [ABSTRACT FROM AUTHOR]

This article describes the evaluation in clinical practice of Kliniderm silicone wound contact layer on 21 patients over a two-week period, with an average of four dressing changes and a minimum of two dressing changes. An evaluation form was completed at each dressing change; aspects being evaluated included patient comfort on application, ease of application, conformability, exudate transfer to secondary dressing, ability to stay in place, ease of removal, patient comfort on removal, the condition of the wound and periwound skin, and the wear time of the dressing. The ratings from each evaluation form were collated and an average rating was calculated for each category. [ABSTRACT FROM AUTHOR]

This post-market evaluation assessed the performance of ActivHeal® Aquafiber™ Extra dressing and gathered feedback from clinicians using it to treat a variety of wounds. The primary outcomes were the progression to healing through exudate management and maintenance of a moist wound healing environment. The evaluation took place across three sites in the UK. Forty-three patients were treated according to instructions to use and standard local practice. Data was collected at every dressing change. Aquafiber® Extra use had positive effects on exudate levels, periwound condition and tissue type(s) within the wound bed. The majority of wounds reduced in size during the evaluation period and three completely healed. Overall, clinician and patient satisfaction was high. No adverse events were reported. The results suggest Aquafiber® Extra use in clinical practice is safe, effective and acceptable to practitioners and patients. [ABSTRACT FROM AUTHOR]

The Wounds UK Best Practice Statement 'Improving holistic assessment of chronic wounds' emphasises the need for wide-ranging assessment that considers the impact of all aspects of the patient's health and wellbeing on the healing process. Each best practice statement has an accompanying 'Patient Expectation', which indicates to patients what to expect in care. This article provides a guide to the Patient Expectations and how to discuss these with your patients to engage them in their treatment. [ABSTRACT FROM AUTHOR]

This article describes the evaluation in clinical practice of a new absorbent silicone adhesive foam dressing on 20 wounds over three dressing changes. Aspects of the evaluation included pain, ease of dressing removal, exudate handling, conformability of the dressing and ease of use. [ABSTRACT FROM AUTHOR]

Slow-healing, chronic wounds have a negative impact on patient wellbeing, are challenging for clinicians to manage and are costly to the health economy (Frykberg and Banks, 2015). Woulgan is a newly available wound care gel containing the active ingredient 2% soluble beta-glucan. Beta-glucan has immunomodulating properties and has been shown to kick-start the healing of slow-healing wounds. A working group of key opinion leaders met in January 2018 to determine the potential role of Woulgan gel in slow-healing wounds, such as diabetic foot ulcers, pressure ulcers and venous leg ulcers, and to develop a decision pathway for clinical practice to support clinicians in escalating treatment promptly to avoid unnecessary impact on patient wellbeing and costs. The group's consensus recommendations on appropriate use are presented here. [ABSTRACT FROM AUTHOR]

The management of exudate is an essential requirement in wound care. It is important that an optimal moist environment is created and the surrounding skin protected from the risk of maceration and subsequent risk of infection. Selected antimicrobial dressings for wounds aim to manage exudate levels, maintain a moist wound environment, aid progression and reduce any signs of infection. This article reports on how the ActivHeal Aquafiber Ag dressing performs on a diverse range of patients with complex infected and non-infected wounds. [ABSTRACT FROM AUTHOR]

The article discusses the highlights of the Made Easy workshop held during the Wounds UK annual conference on November 10, 2015. The workshop's objective is to provide guidance in dealing with challenges of exudate management. During the event, participants were able to have an experience of using Sorbion Sachet S dressings to assist with exudate management.

There are a number of mechanisms at play that can delay wound healing. Wounds can become stuck in a prolonged inflammatory stage resulting in high volumes of wound exudate, which contains agents that contribute to delayed healing. Exudate plays an essential role in wound healing but at excessive volumes it can also facilitate biofilm formation, which can further delay healing. Maintaining optimum levels of exudate is vital for healthy wound healing, as is the prevention or disruption of biofilm formation in the wound bed. This article also looks at Sorbion Sachet S® (BSN medical), a tried- and-tested superabsorbent dressing, which is now back on the Drug Tariff, but at a lower price. This article discusses the mechanisms used in the reintroduced superabsorbent dressing and how it provides a cost-effective solution to the problem of treating highly exuding chronic wounds where clinical efficacy and budgetary concerns are both top priorities. [ABSTRACT FROM AUTHOR]

The article offers brief information on SILVERCEL, a silver-containing wound care dressing from Systagenix which features less pain, exudate level management and less bleeding during change of dressing and mentions that VULCAN study was conducted for evaluating this product.

This survey aimed to identify and quantify the demographic characteristics, treatment objectives, and wound characteristics of patients from five English NHS Trusts receiving wound treatment. Data from 4772 patients (59.8% female; 79.7% aged >65 years) were received. Approximately half were leg wounds. Most patients had one or more comorbidity,most commonly vascular and cardiovascular. The majority of wounds were <3 months' duration and had no associated infection indicators (a small minority had ≤3 infection indicators). Swabbing was considerably more common in wounds showing no primary infection indicators than in infected wounds. Nurses were most commonly involved with dressing changes. Protecting granulation was the most common treatment objective and dressings were changed most commonly twice-weekly as a scheduled care change. No significant differences in wound or patient characteristics were observed between Trusts. [ABSTRACT FROM AUTHOR]

The article presents four case studies describing the overall acceptability of Durafiber to a number of patients with a variety of different wound types by clinical staff. They included a man in his early 80s with a history of venous ulceration, a female in her 80s with a mixed aetiology leg ulcer, and a woman in her late 90s treated for a toe pressure ulcer. All of them responded positively ti treatment with a Durafiber dressing. The advantages offered by a Durafiber dressing are highlighted.

In spring 2011, a multidisciplinary group of clinicians formed a post-launch focus group to discuss their experiences of using Adaptic Touch® non-adherent dressing in clinical practice. The information gained adds to the research already available on the product, which was presented in a review (Bianchi and Gray, 2011) and suggested that the in vivo evidence, along with pre-launch focus groups and case reports, indicated that the product performed well in both laboratory and clinical settings. The post-launch focus group discussed properties such as initial adherence to the wound bed, ease of application and removal, atraumatic dressing changes and cost-effectiveness, offering an invaluable insight into how the product functions in practice. [ABSTRACT FROM AUTHOR]

Highlights the implementation of applied wound management in several types of wounds. Leg ulcer; Mixed aetiology ulceration; Neuropathic ulcer.

Presents a study which assessed the role of the H[sup +]/K[sup +]-ATPase Beta-subunit on epithelial cell development. Materials and methods; Results; Discussion.

Neutral 8-(5-iodo- n-pentyl)-3-(η5-penta­methyl­cyclo­pentadi­enyl)- arachno-3-rhoda-7,8-di­thia­undecaborane, [Rh(C5H19B8­IS2)­(C10H15)], obtained from the [ arachno-7,8-S2B9H10]− anion by treatment with I(CH2)5I followed by [Rh(C5Me5)Cl2]2 and N, N, N′, N′-tetra­methyl-1,8-di­amino­naphthalene, has the 11-vertex cluster geometry of [ arachno-7,8-S2B9H10]−, but with an {Rh(C5Me5)} unit in the 3-position instead of a {BH} unit, and with a -(CH2)5I chain attached exo to an S atom. [ABSTRACT FROM AUTHOR]